Literature DB >> 24268083

Use of interrupted time series analysis in evaluating health care quality improvements.

Robert B Penfold1, Fang Zhang.   

Abstract

Interrupted time series (ITS) analysis is arguably the strongest quasi-experimental research design. ITS is particularly useful when a randomized trial is infeasible or unethical. The approach usually involves constructing a time series of population-level rates for a particular quality improvement focus (eg, rates of attention-deficit/hyperactivity disorder [ADHD] medication initiation) and testing statistically for a change in the outcome rate in the time periods before and time periods after implementation of a policy/program designed to change the outcome. In parallel, investigators often analyze rates of negative outcomes that might be (unintentionally) affected by the policy/program. We discuss why ITS is a useful tool for quality improvement. Strengths of ITS include the ability to control for secular trends in the data (unlike a 2-period before-and-after t test), ability to evaluate outcomes using population-level data, clear graphical presentation of results, ease of conducting stratified analyses, and ability to evaluate both intended and unintended consequences of interventions. Limitations of ITS include the need for a minimum of 8 time periods before and 8 after an intervention to evaluate changes statistically, difficulty in analyzing the independent impact of separate components of a program that are implemented close together in time, and existence of a suitable control population. Investigators must also be careful not to make individual-level inferences when population-level rates are used to evaluate interventions (though ITS can be used with individual-level data). A brief description of ITS is provided, including a fully implemented (but hypothetical) study of the impact of a program to reduce ADHD medication initiation in children younger than 5 years old and insured by Medicaid in Washington State. An example of the database needed to conduct an ITS is provided, as well as SAS code to implement a difference-in-differences model using preschool-age children in California as a comparison group.
Copyright © 2013 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interrupted time series; quality improvement; quasi-experimental; research design

Mesh:

Substances:

Year:  2013        PMID: 24268083     DOI: 10.1016/j.acap.2013.08.002

Source DB:  PubMed          Journal:  Acad Pediatr        ISSN: 1876-2859            Impact factor:   3.107


  277 in total

1.  Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.

Authors:  Laura Barrie Smith; Nihar R Desai; Bryan Dowd; Alexander Everhart; Jeph Herrin; Lucas Higuera; Molly Moore Jeffery; Anupam B Jena; Joseph S Ross; Nilay D Shah; Pinar Karaca-Mandic
Journal:  Int J Health Econ Manag       Date:  2020-04-30

2.  Pediatric Outcomes After Regulatory Mandates for Sepsis Care.

Authors:  Kristin H Gigli; Billie S Davis; Jonathan G Yabes; Chung-Chou H Chang; Derek C Angus; Tina Batra Hershey; Jennifer R Marin; Grant R Martsolf; Jeremy M Kahn
Journal:  Pediatrics       Date:  2020-07       Impact factor: 7.124

3.  Design, analysis, power, and sample size calculation for three-phase interrupted time series analysis in evaluation of health policy interventions.

Authors:  Bo Zhang; Wei Liu; Stephenie C Lemon; Bruce A Barton; Melissa A Fischer; Colleen Lawrence; Elizabeth J Rahn; Maria I Danila; Kenneth G Saag; Paul A Harris; Jeroan J Allison
Journal:  J Eval Clin Pract       Date:  2019-08-19       Impact factor: 2.431

4.  Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation.

Authors:  David J Taber; Derek DuBay; John W McGillicuddy; Satish Nadig; Charles F Bratton; Kenneth D Chavin; Prabhakar K Baliga
Journal:  J Am Coll Surg       Date:  2017-01-31       Impact factor: 6.113

5.  Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.

Authors:  Marjolein M J Zanders; Harm R Haak; Myrthe P P van Herk-Sukel; Lonneke V van de Poll-Franse; Jeffrey A Johnson
Journal:  Diabetologia       Date:  2015-02-01       Impact factor: 10.122

6.  Evaluation of a nudge intervention providing simple feedback to clinicians of the consequence of radiation exposure on demand for computed tomography: a controlled study.

Authors:  Sarah Lewis; Ben Young; Peter Thurley; Dominick Shaw; Jo Cranwell; Rob Skelly; Tessa Langley; Mark Norwood; Nigel Sturrock; Andrew Fogarty
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

7.  Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results From an Interrupted Time Series Study.

Authors:  Julie Gandrup; Jing Li; Zara Izadi; Milena Gianfrancesco; Torkell Ellingsen; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-01-09       Impact factor: 4.794

8.  Estimating population effects of vaccination using large, routinely collected data.

Authors:  M Elizabeth Halloran; Michael G Hudgens
Journal:  Stat Med       Date:  2017-07-19       Impact factor: 2.373

9.  Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.

Authors:  Geoffrey E Hayden; Rachel E Tuuri; Rachel Scott; Joseph D Losek; Aaron M Blackshaw; Andrew J Schoenling; Paul J Nietert; Greg A Hall
Journal:  Am J Emerg Med       Date:  2015-08-28       Impact factor: 2.469

10.  Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.

Authors:  Kai Yeung; Anirban Basu; Ryan N Hansen; John B Watkins; Sean D Sullivan
Journal:  Med Care       Date:  2017-02       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.